Tag: Anticoagulants
Pharmacist Prescribing Can Reduce Stroke Risk in A-Fib Patients
Findings seen for pharmacist prescribing compared with usual care in older adults at high risk for stroke
Low Incidence of Delayed Intracranial Hemorrhage Seen in Seniors After Head Injury
No differences seen in rates of delayed ICH between those who have been versus those who have not been prescribed anticoagulants
Disparities in Direct Oral Anticoagulant Initiation Have Declined in Recent Years
Findings seen for Black and Hispanic patients with atrial fibrillation versus White patients
ASA: Door-to-Treatment Time Tied to Survival in Anticoagulation-Linked ICH
Reduced mortality and discharge to hospital seen with DTT of 60 minutes or less among ICH patients receiving anticoagulation reversal
Ischemic Strokes Less Severe With Left Atrial Appendage Closure in A-Fib
Ischemic stroke less often disabling or fatal with left atrial appendage closure than direct oral anticoagulant prophylaxis
Bleeding Higher With Standard-Dose DOACs in Nonvalvular A-Fib
Higher rate of bleeding seen with standard- versus reduced-dose DOACs in patients 65 years and older
Incident A-Fib Linked to Increased Risk of Mild Cognitive Impairment
Risk of MCI not increased for patients with incident a-fib receiving digoxin treatment or anticoagulant and amiodarone treatment
DOACs Reduce Dementia Risk Versus Warfarin in A-Fib
Significant reductions were seen in dementia risk for rivaroxaban, apixaban, and dabigatran versus warfarin in network meta-analysis
Apixaban Has Lower Bleeding Risk for Initial Anticoagulation for Venous Thromboembolism
During extended treatment, bleeding risk was similar for apixaban and rivaroxaban
Prolonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE
Findings seen among adults prescribed warfarin, DOACs beyond six months after acute venous thromboembolism
